「这让我很惊讶,居然存在关联」:对类风湿关节炎风险个体接受牙周治疗可接受性的定性研究
本研究通过半结构化访谈探讨抗CCP阳性类风湿关节炎风险个体及医护人员对牙周治疗作为潜在预防措施的可接受性。共访谈19名抗CCP阳性风险个体和11名医护人员,采用反思性主题分析及基于预设构念的演绎编码。识别出理解风险、口腔健康认知与体验、口腔健康治疗与维护三大主题,结论认为涉及预防性牙周治疗的临床试验具有潜在可接受性。
要点
- 抗CCP阳性风险个体和医护人员均认为寻求牙科治疗可能受牙科恐惧、治疗费用或无法获得牙医服务阻碍。
- 口腔健康信息应针对个体量身定制。
- 抗CCP阳性风险个体可能不愿服用预防性药物,但涉及预防性牙周治疗的临床试验具有潜在可接受性。
核心结论
- 牙周病在类风湿关节炎风险个体中常见,但口腔健康不佳的影响可能未被充分理解。
- 口腔健康信息应针对个体量身定制。
- 抗CCP阳性风险个体和医护人员指出寻求牙科治疗可能受牙科恐惧、治疗费用或无法获得牙医服务阻碍。
- 抗CCP阳性风险个体可能不愿服用预防性药物,但涉及预防性牙周治疗的临床试验具有潜在可接受性。
研究设计与样本
- 对19名抗CCP阳性类风湿关节炎风险个体和11名医护人员进行半结构化访谈。
- 风险参与者数据采用反思性主题分析,医护人员数据基于预设构念进行演绎编码。
主要发现
- 共识别3个主题(6个亚主题):理解风险(对共享风险因素的知识;信息与沟通)、口腔健康认知与体验(牙科干预和口腔健康维护的个人挑战与机会;外部障碍)、口腔健康治疗与维护(以预防类风湿关节炎为目标做出 口腔健康改变;参与牙周研究的可接受性)。
- 抗CCP阳性风险个体和医护人员指出寻求牙科治疗可能受牙科恐惧、治疗费用或无法获得牙医服务阻碍。
- 抗CCP阳性风险个体可能不愿服用预防性药物,但涉及预防性牙周治疗的临床试验具有潜在可接受性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Current evidence suggests that periodontal disease could be a causal risk factor for rheumatoid arthritis (RA) onset and progression. Earlier periodontal intervention in individuals at risk of RA could provide a unique opportunity to prevent or delay the onset of RA. This study aimed to explore the acceptability of periodontal treatment as a measure to potentially prevent RA among at-risk individuals and healthcare professionals. METHODS: Semistructured interviews were conducted with anti-CCP positive at-risk individuals (CCP+ at risk) and a range of healthcare professionals. At-risk participant data were analysed using reflexive thematic analysis; subsequent coding of healthcare professional data was deductive, based on a preidentified set of constructs. RESULTS: Nineteen CCP+ at-risk and 11 healthcare professionals participated. Three themes (six subthemes) were identified: (1) understanding risk (knowledge of shared at-risk factors; information and communication); (2) oral health perceptions and experiences (personal challenges and opportunities for dental intervention and oral health maintenance; external barriers) and (3) oral health treatment and maintenance (making oral health changes with the aim of preventing RA; acceptability of participation in periodontal research). CONCLUSIONS: Periodontal disease is common in individuals at risk of RA, but the impact of poor oral health may not be well understood. Oral health information should be tailored to the individual. CCP+ at-risk participants and healthcare professionals identified seeking dental treatment can be hindered by dental phobia, treatment costs or inability to access dentists. While CCP+ at-risk individuals may be reluctant to take preventive medications, a clinical trial involving preventive periodontal treatment is potentially acceptable.
引用
- Chapman LS, Vinall-Collier K, Siddle HJ, et al. 'It surprised me a lot that there is a link': a qualitative study of the acceptability of periodontal treatment for individuals at risk of rheumatoid arthritis. RMD Open. 2023. PMID: 37156573. doi:10.1136/rmdopen-2023-003099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。